288 related articles for article (PubMed ID: 19772666)
1. Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.
Pearen MA; Ryall JG; Lynch GS; Muscat GE
BMC Genomics; 2009 Sep; 10():448. PubMed ID: 19772666
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
3. The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle.
Pearen MA; Myers SA; Raichur S; Ryall JG; Lynch GS; Muscat GE
Endocrinology; 2008 Jun; 149(6):2853-65. PubMed ID: 18325999
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice.
Koopman R; Gehrig SM; Léger B; Trieu J; Walrand S; Murphy KT; Lynch GS
J Physiol; 2010 Dec; 588(Pt 23):4811-23. PubMed ID: 20937713
[TBL] [Abstract][Full Text] [Related]
5. Changes in skeletal muscle gene expression following clenbuterol administration.
Spurlock DM; McDaneld TG; McIntyre LM
BMC Genomics; 2006 Dec; 7():320. PubMed ID: 17181869
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses.
Ryall JG; Sillence MN; Lynch GS
Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501
[TBL] [Abstract][Full Text] [Related]
7. Using AAV vectors expressing the β2-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size.
Hagg A; Colgan TD; Thomson RE; Qian H; Lynch GS; Gregorevic P
Sci Rep; 2016 Mar; 6():23042. PubMed ID: 26972746
[TBL] [Abstract][Full Text] [Related]
8. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
[TBL] [Abstract][Full Text] [Related]
9. The orphan nuclear receptor, NOR-1, is a target of beta-adrenergic signaling in skeletal muscle.
Pearen MA; Ryall JG; Maxwell MA; Ohkura N; Lynch GS; Muscat GE
Endocrinology; 2006 Nov; 147(11):5217-27. PubMed ID: 16901967
[TBL] [Abstract][Full Text] [Related]
10. The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis.
Wills LP; Trager RE; Beeson GC; Lindsey CC; Peterson YK; Beeson CC; Schnellmann RG
J Pharmacol Exp Ther; 2012 Jul; 342(1):106-18. PubMed ID: 22490378
[TBL] [Abstract][Full Text] [Related]
11. Nur77 regulates lipolysis in skeletal muscle cells. Evidence for cross-talk between the beta-adrenergic and an orphan nuclear hormone receptor pathway.
Maxwell MA; Cleasby ME; Harding A; Stark A; Cooney GJ; Muscat GE
J Biol Chem; 2005 Apr; 280(13):12573-84. PubMed ID: 15640143
[TBL] [Abstract][Full Text] [Related]
12. Don't 'agonise' over the mechanisms underlying beta-agonist-induced muscle hypertrophy!
Atherton PJ; Szewczyk NJ
J Physiol; 2011 Jan; 589(Pt 1):1-2. PubMed ID: 21224244
[No Abstract] [Full Text] [Related]
13. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
14. Chronic beta2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity.
Ryall JG; Schertzer JD; Murphy KT; Allen AM; Lynch GS
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2587-95. PubMed ID: 18408128
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury.
Ryall JG; Schertzer JD; Alabakis TM; Gehrig SM; Plant DR; Lynch GS
J Appl Physiol (1985); 2008 Jul; 105(1):165-72. PubMed ID: 18436698
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived
Koziczak-Holbro M; Rigel DF; Dumotier B; Sykes DA; Tsao J; Nguyen NH; Bösch J; Jourdain M; Flotte L; Adachi Y; Kiffe M; Azria M; Fairhurst RA; Charlton SJ; Richardson BP; Lach-Trifilieff E; Glass DJ; Ullrich T; Hatakeyama S
J Pharmacol Exp Ther; 2019 May; 369(2):188-199. PubMed ID: 30819762
[TBL] [Abstract][Full Text] [Related]
17. Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
Toledo M; Busquets S; Penna F; Zhou X; Marmonti E; Betancourt A; Massa D; López-Soriano FJ; Han HQ; Argilés JM
Int J Cancer; 2016 Apr; 138(8):2021-9. PubMed ID: 26595367
[TBL] [Abstract][Full Text] [Related]
18. Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.
Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
J Pharmacol Sci; 2008 Aug; 107(4):393-400. PubMed ID: 18678986
[TBL] [Abstract][Full Text] [Related]
19. β
Scholpa NE; Simmons EC; Tilley DG; Schnellmann RG
Exp Neurol; 2019 Dec; 322():113064. PubMed ID: 31525347
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.
Ohnuki Y; Umeki D; Mototani Y; Shiozawa K; Nariyama M; Ito A; Kawamura N; Yagisawa Y; Jin H; Cai W; Suita K; Saeki Y; Fujita T; Ishikawa Y; Okumura S
Physiol Rep; 2016 May; 4(10):. PubMed ID: 27207782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
